- Home
- ATXS vs BWFG Comparison
ATXS vs BWFG Comparison
Compare ATXS & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- BWFG
- Stock Information
- Founded
- ATXS 2008
- BWFG 2002
- Country
- ATXS United States
- BWFG United States
- Employees
- ATXS N/A
- BWFG N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- BWFG Major Banks
- Sector
- ATXS Health Care
- BWFG Finance
- Exchange
- ATXS Nasdaq
- BWFG Nasdaq
- Market Cap
- ATXS 401.2M
- BWFG 333.1M
- IPO Year
- ATXS 2015
- BWFG N/A
- Fundamental
- Price
- ATXS $7.52
- BWFG $43.08
- Analyst Decision
- ATXS Buy
- BWFG Buy
- Analyst Count
- ATXS 6
- BWFG 2
- Target Price
- ATXS $32.00
- BWFG $42.00
- AVG Volume (30 Days)
- ATXS 298.2K
- BWFG 29.8K
- Earning Date
- ATXS 08-12-2025
- BWFG 10-27-2025
- Dividend Yield
- ATXS N/A
- BWFG 1.86%
- EPS Growth
- ATXS N/A
- BWFG N/A
- EPS
- ATXS N/A
- BWFG 2.64
- Revenue
- ATXS N/A
- BWFG $81,749,000.00
- Revenue This Year
- ATXS N/A
- BWFG $63.87
- Revenue Next Year
- ATXS N/A
- BWFG $13.42
- P/E Ratio
- ATXS N/A
- BWFG $16.29
- Revenue Growth
- ATXS N/A
- BWFG 0.32
- 52 Week Low
- ATXS $3.56
- BWFG $26.39
- 52 Week High
- ATXS $12.92
- BWFG $43.38
- Technical
- Relative Strength Index (RSI)
- ATXS 64.14
- BWFG 68.54
- Support Level
- ATXS $6.50
- BWFG $41.55
- Resistance Level
- ATXS $6.82
- BWFG $43.38
- Average True Range (ATR)
- ATXS 0.44
- BWFG 0.85
- MACD
- ATXS 0.07
- BWFG 0.03
- Stochastic Oscillator
- ATXS 96.62
- BWFG 92.21
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.